MYC on the Path to Cancer

Dang, Chi V.·2012·Cell
DOI 10.1016/j.cell.2012.03.003

Cited by (1,009)

Items 601–700 of 1,009

  1. Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges
    Ubanako, Philemon, Mirza, Sheefa, Ruff, Paul, Penny, Clement · 2024 · Frontiers in Molecular Biosciences
  2. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies
    Manoela Marques Ortega, Harshita Bhatnagar, A-P Lin, Lili Wang, Jon Christopher Aster, Heinz Sill, Ricardo C.T. Aguiar · 2014 · Leukemia
  3. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α
    Cheng Yeh Chen, Shaoxin Cai, Guihua Wang, Xiaonian Cao, Xi Yang, Xuelai Luo, Yongdong Feng, Junbo Hu · 2012 · Biochemical and Biophysical Research Communications
  4. MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells
    Aihong Mao, Qiuyue Zhao, Xin Zhou, Chao Sun, Jing Si, Rong Zhou, Lu Gan, Hong Zhang · 2016 · Scientific Reports
  5. The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas
    Aleco D’Andrea, Ilaria Gritti, Paola Nicoli, Marco Giorgio, Mirko Doni, Annalisa Conti, Valerio Bianchi, Lucia Casoli, Arianna Sabò, Alexandre Mironov et al. · 2016 · Oncotarget
  6. Targeting Wnt/β‐catenin and PI3K/Akt/mTOR pathways in T‐cell acute lymphoblastic leukemia
    Cecilia Evangelisti, Francesca Chiarini, Alessandra Cappellini, Francesca Paganelli, Milena Fini, Spartaco Santi, Alberto Maria Martelli, Luca Maria Neri, Camilla Evangelisti · 2020 · Journal of Cellular Physiology
  7. Benzo[a]pyrene promotes gastric cancer cell proliferation and metastasis likely through the Aryl hydrocarbon receptor and ERK-dependent induction of MMP9 and c-myc
    Yucai Wei, Lei Zhao, Wenting He, Jingwei Yang, Chunyu Geng, Yusheng Chen, Tao Liu, Hao Chen, Yumin Li · 2016 · International Journal of Oncology
  8. SUMO-Targeted Ubiquitin Ligases and Their Functions in Maintaining Genome Stability
    Ya‐Chu Chang, Marissa K. Oram, Anja‐Katrin Bielinsky · 2021 · International Journal of Molecular Sciences
  9. Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
    Kyung‐min Lee, Chang-Ching A. Lin, Alberto Servetto, Joonbeom Bae, Vishal Kandagatla, Dan Ye, Gun Min Kim, Dhivya R. Sudhan, Saurabh Mendiratta, Paula I. González Ericsson et al. · 2022 · Cancer Immunology Research
  10. Calpains and cancer: Friends or enemies?
    Daniele Moretti, Barbara Del Bello, Giulia Allavena, Emilia Maellaro · 2014 · Archives of Biochemistry and Biophysics
  11. Genetic Variants Associated with Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study
    Giuseppe Matullo, Simonetta Guarrera, Marta Betti, Giovanni Fiorito, Daniela Ferrante, Floriana Voglino, Gemma Cadby, Cornelia Di Gaetano, Fabio Rosa, ALESSIA ERIKA RUSSO et al. · 2013 · PLoS ONE
  12. A subset of Drosophila Myc sites remain associated with mitotic chromosomes colocalized with insulator proteins
    Jingping Yang, Elizabeth Sung, Paul Donlin-Asp, Victor G. Corces · 2013 · Nature Communications
  13. Computational study of molecular electrostatic potential, docking and dynamics simulations of gallic acid derivatives as ABL inhibitors
    K. R. Raghi, Daisy Rajaian Sherin, M. J. Saumya, P.S. Arun, V.N. Sobha, Thanathu Krishnan Manojkumar · 2018 · Computational Biology and Chemistry
  14. Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response
    Yonglong Zhang, Yanfeng Liu, Jinlin Duan, Hui Wang, Yuchen Zhang, Ke Qiao, Jian Wang · 2019 · Cell Cycle
  15. Tracking the expression of therapeutic protein targets in rare cells by antibody-mediated nanoparticle labelling and magnetic sorting
    Mahmoud Labib, Zongjie Wang, Sharif Uddin Ahmed, Reza M. Mohamadi, Bill T. V. Duong, Brenda J. Green, Edward Hartley Sargent, Shana O. Kelley · 2020 · Nature Biomedical Engineering
  16. Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals
    Yulong Su, Carl Pelz, Tao Huang, Kristof A. Torkenczy, Xiaoyan Wang, Allison E. Cherry, Colin J. Daniel, Juan Boo Liang, Xiaolin Nan, Mu‐Shui Dai et al. · 2018 · Genes & Development
  17. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein
    Yamin Shang · 2018 · Biomedicine & Pharmacotherapy
  18. Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis
    Shiting Li, De Huang, Shengqi Shen, Yongping Cai, Songge Xing, Gongwei Wu, Zetan Jiang, Yijie Hao, Mengqiu Yuan, Nana Wang et al. · 2020 · Nature Metabolism
  19. Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research
    Sirin Saranyutanon, Sachin Kumar Deshmukh, Santanu Dasgupta, Sachin Gopalkrishna Pai, Seema Singh, Ajay P. Singh · 2020 · Cancers
  20. Deciphering metabolic rewiring in breast cancer subtypes
    Martin P. Ogrodzinski, Jamie J. Bernard, Sophia Y. Lunt · 2017 · Translational research
  21. Lipid desaturation-associated endoplasmic reticulum stress regulates MYCN gene expression in hepatocellular carcinoma cells
    Xian‐Yang Qin, Ting Su, Wenkui Yu, Soichi Kojima · 2020 · Cell Death and Disease
  22. A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267
    Jing Gong, Jianbo Tian, Jicheng Lou, X. Wang, Juntao Ke, Jie Li, Yi Yang, Yuanyuan Gong, Ying Zhu, D. Zou et al. · 2017 · Annals of Oncology
  23. Targeting MYC Proteins for Tumor Therapy
    Elmar Wolf, Martin Eilers · 2019 · Annual Review of Cancer Biology
  24. Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts
    Pawan Noel, Shaimaa Hussein, Serina Ng, Corina E. Antal, Wei Lin, Emily Rodela, Priscilla Delgado, Sanna Naveed, Michael Downes, Yin Chun Lin et al. · 2020 · Oncogenesis
  25. MYCN recruits the nuclear exosome complex to RNA polymerase II to prevent transcription-replication conflicts
    Dimitrios Papadopoulos, Daniel Solvie, Apoorva Baluapuri, Theresa Endres, Stefanie Anh Ha, Steffi Herold, Jacqueline Kalb, Celeste Giansanti, Christina Schülein‐Völk, Carsten Patrick Ade et al. · 2021 · Molecular Cell
  26. Multi-transcriptome analysis following an acute skeletal muscle growth stimulus yields tools for discerning global and MYC regulatory networks
    Kevin A. Murach, Zhengye Liu, Baptiste Jude, Vandré C. Figueiredo, Yuan Wen, Sabin Khadgi, Seongkyun Lim, Francielly Morena da Silva, Nicholas Perry Greene, Johanna T. Lanner et al. · 2022 · Journal of Biological Chemistry
  27. The effects of MYC on tumor immunity and immunotherapy
    Jiajin Li, Tingyu Dong, Zhen Wu, Dacheng Zhu, Hao Gu · 2023 · Cell Death Discovery
  28. Genomic Profiling of Human Penile Carcinoma Predicts Worse Prognosis and Survival
    Ariane Fidelis Busso-Lopes, Fábio Albuquerque Marchi, Hellen Kuasne, Cristovam Scapulatempo‐Neto, José Carlos S. Trindade-Filho, Carlos Márcio N. de Jesus, Ademar Lopes, Gustavo Cardoso Guimarães, Sílvia Regina Rogatto · 2014 · Cancer Prevention Research
  29. Inactivation of MYC reverses tumorigenesis
    Ye Li, Stephanie C. Casey, Dean W. Felsher · 2014 · Journal of Internal Medicine
  30. Metabolic changes in cancer cells upon suppression of MYC
    Elena Ansó, Andrew R. Mullen, Dean W. Felsher, José Manuel Matés, Ralph J. DeBerardinis, Navdeep S. Chandel · 2013 · Cancer & Metabolism
  31. Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer
    Wei Bian, Xiaohui Zhou, Ling Xu, Chaohui Rong, Ce Shen, Yi Lü · 2016 · OncoTargets and Therapy
  32. MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability
    Dharmendra D Dingar, William B. Tu, Diana Resetca, Corey Lourenco, Aaliya Tamachi, Jason De Melo, Kathleen E. Houlahan, Manpreet Kalkat, Pak-Kei Chan, Paul Christopher Boutros et al. · 2018 · Nature Communications
  33. Crystal structure of the major quadruplex formed in the promoter region of the human c-MYC oncogene
    Sascha Stump, Tung‐Chung Mou, Stephen R. Sprang, Nicholas R. Natale, Howard D. Beall · 2018 · PLoS ONE
  34. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation
    Ke Li, Feng Wang, Zhao-na Yang, Tingting Zhang, Yufen Yuan, Chen-xi Zhao, Zaiwuli Yeerjiang, Bing Cui, Fang Hua, Xiaoxi Lv et al. · 2020 · Nature Communications
  35. Molecular Mechanisms of MYCN Dysregulation in Cancers
    Ruochen Liu, Pengfei Shi, Zhongze Wang, Chaoyu Yuan, Hongjuan Cui · 2021 · Frontiers in Oncology
  36. MYC Cofactors: Molecular Switches Controlling Diverse Biological Outcomes
    Stephan Hann · 2014 · Cold Spring Harbor Perspectives in Medicine
  37. Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer
    Kuniaki Sato, Takaaki Masuda, Qingjiang Hu, Taro Tobo, Sarah Gillaspie, Atsushi Niida, Mackenzie M. Thornton, Yousuke Kuroda, Hidetoshi Eguchi, Takashi Nakagawa et al. · 2019 · EBioMedicine
  38. Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application
    Shigeo Saito, Chia‐Chen Ku, Kenly Wuputra, Jia-Bin Pan, Chang‐Shen Lin, Ying‐Chu Lin, Deng‐Chyang Wu, Kazunari K. Yokoyama · 2022 · Journal of Personalized Medicine
  39. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells
    Carolyn A. Goard, Michelle Chan‐Seng‐Yue, Peter Mullen, Ariel D. Quiroga, Amanda R. Wasylishen, James W. Clendening, Dorota H.S. Sendorek, Syed Aleem Haider, Richard S. Lehner, Paul Christopher Boutros et al. · 2013 · Breast Cancer Research and Treatment
  40. Targeting cancer stem‐like cells in glioblastoma and colorectal cancer through metabolic pathways
    Ulf D. Kahlert, Steven M. Mooney, Manabu Natsumeda, Hans‐Jakob Steiger, Jarek Maciaczyk · 2016 · International Journal of Cancer
  41. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis
    Daniela Barros‐Silva, Pedro Costa‐Pinheiro, Henrique O. Duarte, Elsa Sousa, Adriane Feijó Evangelista, Inês C. R. Graça, Isa C. Carneiro, Ana Teresa Martins, Jorge Oliveira, André Lopes Carvalho et al. · 2018 · Cell Death and Disease
  42. An update of knowledge on PD‐L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives
    Daniel Lenouvel, Miguel Ángel González‐Moles, Asmae Talbaoui, Pablo Ramos‐García, Lucía González‐Ruiz, Isabel Ruiz‐Ávila, José Antonio Gil Montoya · 2019 · Oral Diseases
  43. Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
    Yana Pikman, Nicole Ocasio-Martinez, Gabriela Alexe, Boris Dimitrov, Samuel Kitara, Frances F. Diehl, Amanda L. Robichaud, Amy Saur Conway, Linda S. Ross, Angela H. Su et al. · 2021 · Leukemia
  44. A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression
    Austin G. Holmes, J. Brandon Parker, Vinay Sagar, Mihai Ioan Truica, Pritin N. Soni, Huiying Han, Gary E. Schiltz, Sarki Abba Abdulkadir, Debabrata Chakravarti · 2022 · Science Advances
  45. GABA induced by sleep deprivation promotes the proliferation and migration of colon tumors through miR-223-3p endogenous pathway and exosome pathway
    Haijun Bao, Zuojie Peng, Xukai Cheng, Chenxing Jian, Xianguo Li, Yongping Shi, Wenzhong Zhu, Yuan Hu, Mi Jiang, Jia Song et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  46. Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways
    Ji Hyun Kim, Eun Byul Cho, Jongsung Lee, Okkeun Jung, Byung Jun Ryu, Seong Hwan Kim, Jae Youl Cho, Chongsuk Ryou, Sang Yeol Lee · 2015 · Chemico-Biological Interactions
  47. β-catenin regulatesc-MycandCDKN1Aexpression in breast cancer cells
    Jinhua Xu, Yinghua Chen, Dezheng Huo, Andrey Khramtsov, Galina F. Khramtsova, Chunling Zhang, Kathleen H. Goss, Olufunmilayo Ibironke Olopade · 2015 · Molecular Carcinogenesis
  48. The enzymes of human diphosphoinositol polyphosphate metabolism
    MARK P. THOMAS, Barry V. L. Potter · 2013 · FEBS Journal
  49. Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling
    Michaela Lang, Melanie Borgmann, Georg Oberhuber, Rayko Evstatiev, Kristine Jimenez, Kyle W. Dammann, Manuela Jambrich, Vineeta Khare, Christoph Campregher, Robin Ristl et al. · 2013 · Molecular Cancer
  50. The role of the ribosome in the regulation of longevity and lifespan extension
    Alyson W. MacInnes · 2016 · Wiley Interdisciplinary Reviews - RNA
  51. Cellular senescence and protein degradation
    Xavier Deschênes‐Simard, Frédéric Lessard, Marie‐France Gaumont‐Leclerc, Nabeel M. Bardeesy, Gerardo Ferbeyre · 2014 · Cell Cycle
  52. Single Agent and Synergistic Activity of the “First-in-Class” Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma
    Alok Ranjan Singh, Shweta Joshi, Adam M. Burgoyne, Jason Keith Sicklick, Sadakatsu Ikeda, Yuko Kono, Joseph R. Garlich, Guillermo A. Morales, Donald L. Durden · 2016 · Molecular Cancer Therapeutics
  53. Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription
    Giacomo Cossa, Isabelle Röschert, Florian Prinz, Apoorva Baluapuri, Raphael Silveira Vidal, Christina Schülein‐Völk, Yun-Chien Chang, Carsten Patrick Ade, Guido Mastrobuoni, Cyrille Girard et al. · 2020 · Molecular Cell
  54. N-Myc overexpression increases cisplatin resistance in neuroblastoma via deregulation of mitochondrial dynamics
    Casinelli, Gabriella, LaRosa, Jeff, Sharma, Manika, Cherok, Edward, Banerjee, Swati, Branca, Maria, Edmunds, Lia, Wang, Yudong, Sims-Lucas, Sunder, Churley, Luke et al. · 2016 · Cell Death Discovery
  55. Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
    Cargill, Kasey R., Stewart, C. Allison, Park, Elizabeth M., Ramkumar, Kavya, Gay, Carl M., Cardnell, Robert J., Wang, Qi, Diao, Lixia, Shen, Li, Fan, You-Hong et al. · 2021 · Cancer & Metabolism
  56. CBX8 Suppresses Tumor Metastasis via Repressing Snail in Esophageal Squamous Cell Carcinoma
    Gang Wang, Jianjun Tang, Weixiang Zhan, Ruhua Zhang, Meifang Zhang, Dan Liao, Xin Wang, Yuanzhong Wu, Tiebang Kang · 2017 · Theranostics
  57. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
    Sho Kubota, K. Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, M. Oshima, K. Tan, Henry Yang, A. Kanai, Eisaku Iwanaga et al. · 2019 · Nature Communications
  58. OligoTRAFTACs: A generalizable method for transcription factor degradation
    Kusal T. G. Samarasinghe, Elvira An, Miriam A. Genuth, Ling Chu, Scott A. Holley, Craig M. Crews · 2022 · RSC Chemical Biology
  59. Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
    Raymond S. Traweek, Brandon M. Cope, Christina Lynn Roland, Emily Zhi-Yun Keung, Elise F. Nassif, Derek J. Erstad · 2022 · Frontiers in Oncology
  60. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma
    Stefano Amente, Giorgio Milazzo, Maria Cristina Sorrentino, Susanna Ambrosio, Giacomo Di Palo, Luigi Lania, Giovanni Perini, Barbara Majello · 2015 · Oncotarget
  61. The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors
    C Wong, Saurabh V. Laddha, Laura H. Tang, Evan Vosburgh, Arnold J. Levine, Emmanuel Normant, Péter Sandy, C R Harris, C S Chan, Eugenia Y. Xu · 2014 · Cell Death and Disease
  62. Cadmium Modifies the Cell Cycle and Apoptotic Profiles of Human Breast Cancer Cells Treated with 5-Fluorouracil
    Yolande Asara, Juan Antonio Marchal, Esther Carrasco, Houría Boulaiz, Giuliana Solinas, Pasquale Bandiera, María Ángel García, Cristiano Farace, Andrea Montella, Roberto Madeddu · 2013 · International Journal of Molecular Sciences
  63. Mice deficient of Myc super-enhancer region reveal differential control mechanism between normal and pathological growth
    Kashyap Dave, Inderpreet Sur, Jian Yan, Jilin Zhang, Eevi Kaasinen, Fan Zhong, Leander Blaas, Xiaoze Li, Shabnam Kharazi, Charlotte Gustafsson et al. · 2017 · eLife
  64. The NDR/LATS protein kinases in immunology and cancer biology
    Ahmad A.D. Sharif, Alexander Hergovich · 2017 · Seminars in Cancer Biology
  65. HJURP antagonizes CENP-A mislocalization driven by the H3.3 chaperones HIRA and DAXX
    Jonathan Nye, David M. Sturgill, Rajbir K Athwal, Yamini Dalal · 2018 · PLoS ONE
  66. Wnt/β-catenin signaling regulates Helicoverpa armigera pupal development by up-regulating c-Myc and AP-4
    Wei Chen, Wei‐Hua Xu · 2014 · Insect Biochemistry and Molecular Biology
  67. BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
    Grazia Ambrosini, Ashley Sawle, Elgilda Musi, Gary K. Schwartz · 2015 · Oncotarget
  68. Inhibition of MYC attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo
    Irina N. Alimova, Angela M. Pierce, Etienne P. Danis, Andrew M. Donson, Diane K. Birks, Andrea M. Griesinger, Nicholas K. Foreman, Mariarita Santi, Laura Soucek, Sujatha Venkataraman et al. · 2018 · International Journal of Cancer
  69. The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
    Yingxin Pang, Gaigai Bai, Jing Zhao, Xuan Wei, Rui Li, Jie Li, Shunxue Hu, Lu Peng, Peishu Liu, Hongluan Mao · 2022 · Journal of Translational Medicine
  70. Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy
    Yunli Huang, Yongqi Zhen, Yanmei Chen, Shaoguang Sui, Lan Zhang · 2023 · Biochemical Pharmacology
  71. miR ‐494 acts as an anti‐oncogene in gastric carcinoma by targeting c‐myc
    Weiling He, Yuhuang Li, Xinlin Chen, Liya Lu, Bin Tang, Zhixiong Wang, Yunbao Pan, Shirong Cai, Yulong He, Zunfu Ke · 2014 · Journal of Gastroenterology and Hepatology
  72. The Zinc Finger Transcription Factor ZFX Is Required for Maintaining the Tumorigenic Potential of Glioblastoma Stem Cells
    Xiaoguang Fang, Zhi Huang, Wenchao Zhou, Qiulian Wu, Andrew Edward Sloan, Gaoliang Ouyang, Roger E. McLendon, Jennifer S. Yu, Jeremy N. Rich, Shideng Bao · 2014 · Stem Cells
  73. Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis
    Blake R. Wilde, Donald E. Ayer · 2015 · British Journal of Cancer
  74. Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer
    Seong Hwi Hong, Jung Woo Eun, Sung Kyung Choi, Qingyu Shen, Wahn Soo Choi, Jeung‐Whan Han, Suk Woo Nam, Jueng Soo You · 2016 · Oncotarget
  75. Mantle Cell Lymphoma With MYC Rearrangement
    Zhihong Hu, Leonard Jeffrey Medeiros, Zi Chen, Weina Chen, Shaoying Li, Sergej Naumovich Konoplev, Xinyan Y. Lu, Lan V. Pham, Ken H. Young, Wei Wang et al. · 2016 · The American Journal of Surgical Pathology
  76. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells
    Wei Fan, Heping Yang, Ting Liu, Jiaohong Wang, Tony W.H. Li, Nirmala Mavila, Yuanyuan Tang, JinWon Yang, Hui Peng, Jian Tu et al. · 2016 · Hepatology
  77. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis
    Xinxin Cheng, Lixuan Wei, Xudong Huang, Jian Zheng, Mingming Shao, Ting Feng, Jun Li, Yaling Han, Wenle Tan, Wen Tan et al. · 2017 · Gastroenterology
  78. Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells
    Po-Hsiang Chang, Keisuke Sekine, Hsiao‐Mei Chao, Shan‐hui Hsu, Edward Chern · 2017 · Scientific Reports
  79. The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance
    Alpana Kumari, Watson P. Folk, Daitoku Sakamuro · 2017 · Genes
  80. Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs
    Allevato, Michael, Bolotin, Eugene, Grossman, Mark, Mane-Padros, Daniel, Sladek, Frances M., Martinez, Ernest · 2017 · PLOS ONE
  81. Crystal Structures and Nuclear Magnetic Resonance Studies of the Apo Form of the c-MYC:MAX bHLHZip Complex Reveal a Helical Basic Region in the Absence of DNA
    Susan Sammak, Najoua Hamdani, F. Gorrec, Mark D. Allen, Stefan M.V. Freund, Mark Bycroft, Giovanna Zinzalla · 2019 · Biochemistry
  82. Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma
    Taylor Hashiguchi, Nur Bruss, Scott Best, Vi Lam, Olga V. Danilova, Cody J. Paiva, Joelle Wolf, Erin W. Gilbert, Craig Y. Okada, Prabhjot Kaur et al. · 2019 · Molecular Cancer Therapeutics
  83. UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells
    Kenzui Taniue, Tomoatsu Hayashi, Yuki Kamoshida, Akiko Kurimoto, Yasuko Takeda, Lumi Negishi, Kei Iwasaki, Yoshifumi Kawamura, Naoki Goshima, Tetsu Akiyama · 2019 · Oncogene
  84. OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2
    Gang Yang, Guangbing Xiong, Mengyu Feng, Fangyu Zhao, Jiangdong Qiu, Yueze Liu, Zhe Cao, Huanyu Wang, Jinshou Yang, Lei You et al. · 2020 · Molecular Cancer Research
  85. Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer
    Maciej Cieśla, Phuong Cao Thi Ngoc, Eugenia Cordero, Álvaro Sejas Martínez, Mikkel Morsing, Sowndarya Muthukumar, Giulia Beneventi, Magdalena Madej, Roberto Munita, Terese Jönsson et al. · 2021 · Molecular Cell
  86. Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells
    Salah Boudjadi, Julie C. Carrier, J-F Groulx, Jean‐François Beaulieu · 2015 · Oncogene
  87. Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma
    Jonas Ecker, Venu Thatikonda, Gianluca Sigismondo, Florian Selt, Gintvile Valinciute, Ina Oehme, Carina Müller, Juliane L. Buhl, Johannes Ridinger, Diren Usta et al. · 2020 · Neuro-Oncology
  88. Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor
    Markus Welcker, Baiyun Wang, Domnița-Valeria Rusnac, Yasser Hussaini, Jherek Swanger, Ning Zheng, Bruce E. Clurman · 2022 · Science Advances
  89. Expanding the horizons of targeted protein degradation: A non-small molecule perspective
    Xiaowei Huang, Fengbo Wu, Jing Ye, Lian Wang, Xiaoyun Wang, Xiang Li, Gu He · 2024 · Acta Pharmaceutica Sinica B
  90. Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells
    Trent Fowler, Payel Ghatak, David H. Price, Ronald C. Conaway, Joan Weliky Conaway, Cheng‐Ming Chiang, James E. Bradner, Ali Shilatifard, Ananda L. Roy · 2014 · PLoS ONE
  91. Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment
    Omotayo Owomofoyon Erejuwa, Siti Amrah Sulaiman, Mohd Suhaimi Ab Wahab · 2013 · Oxidative Medicine and Cellular Longevity
  92. MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma
    Xiang Zhang, Xiao Zhang, Ting Wang, Lei Wang, Zhijun Tan, Wei Wei, Bo Yan, Jing Zhao, Kaichun Wu, Angang Yang et al. · 2018 · Cancer Letters
  93. Heat Shock Protein 90α–Dependent B‐Cell‐2–Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto‐Oncogene c‐MYC mRNA Stability
    Xueqiong Zhou, Ying Wen, Ye Tian, Meiling He, Xiangyu Ke, Zhizhou Huang, Yangfan He, Lixia Liu, Annette N. D. Scharf, Meiting Lu et al. · 2018 · Hepatology
  94. Gene duplication and neofunctionalization: POLR3G and POLR3GL
    Marianne Renaud, Viviane Praz, Erwann Vieu, Laurence A. Florens, Michael P. Washburn, Philippe Lhôte, Nouria Hernandez · 2013 · Genome Research
  95. A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1
    Dror Hollander, Maya Donyo, Nir Atias, Keren Mekahel, Ze’ev Melamed, Sivan Yannai, Galit Lev-Maor, Asaf Shilo, Schraga Schwartz, Iris Barshack et al. · 2016 · Genome Research
  96. MYC leads the way
    Niranjan Venkateswaran, Maralice Conacci‐Sorrell · 2017 · Small GTPases
  97. Aurora kinase A mediates c‐Myc's oncogenic effects in hepatocellular carcinoma
    Long-Feng Lu, Han Han, Yuan Tian, Wenjuan Li, Jinxiang Zhang, Maohui Feng, Youjun Li · 2014 · Molecular Carcinogenesis
  98. Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo
    Henryk Dudek, Darren H. Wong, Rokhand Arvan, Anee Shah, Kathleen A. Wortham, Bo Ying, Rohan Diwanji, Wei Lan Zhou, Benjamin R. Holmes, Hailin Yang et al. · 2013 · Molecular Therapy
  99. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma
    Liping Dai, Pengfei Ren, Mei Liu, Haruhiko Imai, Eng M. Tan, Jian Ying Zhang · 2014 · Clinical Immunology
  100. Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
    Anne Le, N.V. Rajeshkumar, Anirban Maitra, Chi Van Dang · 2012 · Clinical Cancer Research